论文部分内容阅读
目的:观察复方益母草口服液用于治疗产后恶露不绝的临床疗效。方法:200例产后恶露不绝患者随机分为观察组和对照组各100例,观察组给予复方益母草口服液20 ml,po,tid,对照组给予益母草颗粒15 g,po,tid,两组疗程均为7 d。观察两组治疗后恶露持续时间,小腹疼痛、子宫复旧及产后感染发生情况并评价疗效。结果:观察组患者总有效率为94.0%,明显高于对照组的84.0%(P<0.05)。观察组恶露结束时间短于对照组,腹痛改善和子宫复旧情况明显优于对照组,产后感染发生率少于对照组,差异均具统计学意义(P<0.05)。结论:复方益母草口服液可有效促进产后子宫复旧,用于治疗产后恶露不绝疗效理想,安全性高。
Objective: To observe the clinical efficacy of the compound Motherwort Oral Liquid for the treatment of postpartum lochia. Methods: 200 cases of postpartum lochia patients were randomly divided into observation group and control group of 100 cases, the observation group was given compound Motherwort oral solution 20 ml, po, tid, the control group was given Motherwort particles 15 g, po, tid, two groups of treatment All for 7 days. After treatment, the duration of lochia, abdominal pain, uterine involution and postpartum infection were observed and evaluated. Results: The total effective rate in the observation group was 94.0%, significantly higher than that in the control group (84.0%, P <0.05). The end of lochia in the observation group was shorter than that in the control group. The improvement of abdominal pain and uterine involution were significantly better than that of the control group. The incidence of postpartum infection was less than that of the control group. The difference was statistically significant (P <0.05). Conclusion: The compound Motherwort Oral Liquid can effectively promote postpartum uterine involution and is ideal for treating postpartum lochia with high safety.